Zenopa4d
MSD Animal Health Boosts Rabies Prevention with Major Vaccine Donation
MSD Animal Health donates 6 million rabies vaccines through Afya Program, reinforcing global efforts to combat rabies and ...
Zenopa4d
Evolving Debate on Water Fluoridation’s Effectiveness
Experts reassess water fluoridation's effectiveness as fluoride toothpaste usage rises, affecting policies in regions like ...
Zenopa13d
Procept BioRobotics Launches Landmark Study on Aquablation for Prostate Cancer
Procept BioRobotics' WATER IV PCa trial compares Aquablation to radical prostatectomy in treating localized prostate cancer, ...
Zenopa10d
Roche’s New Breast Cancer Drug Itovebi: FDA Approval and Market Impact
Roche's Itovebi gains FDA approval for breast cancer, challenging Novartis and AstraZeneca with potential $2.3 billion sales.
Zenopa4d
Abbott’s Strategic Expansion in Diabetes Tech Offers Growth Opportunities
Abbott is making significant strides in the diabetes technology sector, with CEO Robert Ford highlighting the potential of continuous glucose monitors (CGMs) to reach a wider market. This growth is ...
Zenopa11d
Siemens Unveils Cloud-Based Engineering Suite
Siemens unveils Capital X, a cloud-based software suite transforming electrical and electronic systems engineering with ...
Zenopa5d
bioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines
BioAffinity Technologies’ (Nasdaq: BIAF) Vice President of Diagnostics, Jennifer Rebeles, Ph.D., was part of a panel of worldwide experts that published the peer-reviewed paper, “Implementation of ...
Zenopa6d
Ovation Agriculture and SRUC Revolutionize Cattle Health with New Dental Gag
Ovation Agriculture, emerging from Scotland’s Rural College, is set to revolutionise cattle health with its new dental gag. This innovative tool, designed to facilitate thorough examination of cows’ ...
Zenopa6d
Imuldosa: New FDA-Approved Biosimilar for Inflammation
The FDA’s recent approval of Imuldosa, developed by Accord BioPharma as a biosimilar to Stelara, marks an expansion in treatments for chronic inflammatory conditions. This approval, encompassing ...
Zenopa7d
Lundbeck’s Acquisition of Longboard Could Revolutionize Neuro-Rare Treatment
Danish pharmaceutical company Lundbeck is making waves in the biopharma industry with its $2.6 billion acquisition of the biotechnology firm Longboard Pharmaceuticals. This strategic move targets the ...
Zenopa8d
Abbott Expands Pulsed Field Ablation Research with FDA Clearance
Abbott, a global leader in healthcare innovation, has received FDA clearance for its advanced cardiac mapping technology. This clearance is a big step in its ongoing clinical studies of pulsed field ...
Zenopa8d
Medtronic Explores Dual-Energy Ablation for VT Treatment
Medtronic, a leading player in medical technology, is evaluating its Affera mapping and ablation system featuring the Sphere-9 catheter for treating ventricular tachycardia (VT). This heart rhythm ...